LabGenius Therapeutics
Developer of next-generation protein-based therapeutics designed to address unmet needs like inflammatory bowel disease. The company's therapeutics engineer protein drugs properties, such as protease ...
Valuation
$85.9M
Market implied
Share Price
N/A
Total Raised
$93.4M
Last Round
N/A